Incidence rate of small cell lung cancer with hyponatremia and analysis of treatment method

[1]

Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association. Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition) [J]. China Oncology, 2024, 34(8): 785-805.

[2]

[3]

[4]

Urologic Chinese Oncology Group. Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition) [J]. China Oncology, 2024, 34(6): 607-618.

[5]

Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology . Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition) [J]. China Oncology, 2024, 34(5): 517-526.

[6]

FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao. Progress in treatment of gynecological cancer in 2023 [J]. China Oncology, 2024, 34(4): 340-360.

[7]

[8]

XU Yonghu, XU Dazhi. Progress and prospects of gastric cancer treatment in the 21st century [J]. China Oncology, 2024, 34(3): 239-249.

[9]

WANG Xuefei, ZHOU Peng, TANG Zhaoqing. New progress and development trend of surgical treatment for gastric cancer [J]. China Oncology, 2024, 34(3): 250-258.

[10]

[11]

Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association . Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition) [J]. China Oncology, 2024, 34(1): 13-66.

[12]

JIANG Lili, MA Yan, ZHANG Tiantian, HUANG Shan. Clinical analysis of 21 cases of primary Ewing sarcoma of the thoracic wall [J]. China Oncology, 2024, 34(1): 74-81.

[13]

[14]

LI Tong, YANG Huijuan. Progress in diagnosis and treatment of mucinous ovarian cancer [J]. China Oncology, 2024, 34(1): 90-96.

[15]

PDF